Klinik Değerlendirme ve Tanı Yöntemleri
Özet
Larinks hastalıkları kliniğe sıklıkla ses kısıklığı, disfaji, solunum problemleri, odinofaji, tek taraflı otalji ile başvurur. Şikayetleri 2 haftadan uzun süredir devam eden hastalar organik nedenler açısından ekarte edilmelidir. Bunun için fizik muayenede hastanın genel durumu, solunumu, sesi değerlendirilir ve gerekirse indirekt laringoskopi ile larinks görüntülenir. Larinksin görüntülemesinde Ultrasonografi(USG),Bilgisayarlı tomografi(BT), Manyetik Rezonans (MR) kullanılabilir. Malignite düşünülen hastalardan anestezi altında direkt laringoskopik muayene ile biyopsi almak gerekir.
Laryngeal diseases most commonly present to the clinic with symptoms such as hoarseness, dysphagia, respiratory problems, odynophagia, and unilateral otalgia. Patients whose complaints persist for longer than two weeks should be evaluated to rule out organic causes.During the physical examination, the patient’s general condition, respiration, and voice quality should be assessed. If necessary, the larynx can be visualized using indirect laryngoscopy. For imaging of the larynx, ultrasonography (USG), computed tomography (CT), and magnetic resonance imaging (MRI) may be utilized. In patients with suspected malignancy, it is necessary to obtain a biopsy under general anesthesia using direct laryngoscopy.
Referanslar
Cohen SM, Kim J, Roy N, Asche C, Courey M. Prevalence and causes of dysphonia in a large treatment-seeking population. Laryngoscope. 2012;122(2):343-348.
George L.Adams, Robert H.Naisel Malignant tu mors of the larynx and hypopharynx In: Cummings Otolaryngology Head and Neck Surgery Fourth Edition Editors: Charles W.Cummings, Paul W. Flint, Lee A. Harker. Philedelphia, Mosby, 2005. 2222-83
Talamini R, Bosetti C, La Vecchia C, et al. Combi ned effect of tobacco and alcohol on laryngeal can cer risk: a case control study. Cancer Causes Con trol 2002; 13(10): 957-64
Smith EM, Summersgill KF, Allen J, Hoffman HT, McCulloch T, Turek LP, Haugen TH. Human papillomavirus and risk of laryngeal cancer. Ann Otol Rhinol Laryngol. 2000 Nov;109(11):1069-76. doi: 10.1177/000348940010901114. PMID: 11090000.
Goyal N, Hennessy M, Lehman E, Lin W, Agudo A, Ahrens W, et al. Risk factors for head and neck cancer in more and less developed countries: Analysis from the INHANCE consortium. Oral Dis [Internet]. 2023 May;29(4):1565–78. http://www.ncbi.nlm.nih.gov/pubmed/35322907
Redaelli de Zinis LO, Nicolai P, Tomenzoli D, Ghizzardi D, Trimarchi M, Cappiello J, Peretti G, Antonelli AR. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck. 2002 Oct;24(10):913-20. doi: 10.1002/hed.10152. PMID: 12369069.
Tuncel Ü, Arda N, Özcan M, İkincioğulları A, Ünal A Ses kısıklığı şikayeti ile gelen hastalardases profilinin değerlendirilmesi. Turkiye Klinikleri Journal of Medical Sciences,2002 22: 124-128.
Donati, E., & Chousidis, C. Electroglottography based real-time voice-toMIDI controller. Neuroscience Informatics,2022: 2(2), 100041.
William B. Armstrong, David E. Vokes, Sunil P. Ver mo Malignant Tumors of the Larynx. In Cummings Otolaryngology Head and Neck Surgery sıxth editi on, Edited By PaulW. Flint, Bruca H.Haughey, Va lerie Luns Philadelphia Elsevier Saunders 2015. 1601-1633
Fleming, Alfred J. et al. “Impact of [18F]‐2‐Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography on Previously Untreated Head and Neck Cancer Patients.” The Laryngoscope 117 (2007): 1173-79
Joshi VM, Wadhwa V, Mukherji SK, Imaging in laryngeal cancers, Indian Journal of Radiology and Imaging 2012; (22):209-226
Hermans R. Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Eur Radiol 2006 Nov;16(11):2386–400. http://www.ncbi.nlm.nih.gov/pubmed/16733680
Ferlito A, Shaha AR, Silver CE, Rinaldo A, Mondin V. Incidence and sites of distant metastases from head and neck cancer. ORL J Otorhinolaryngol Relat Spec [Internet]. 2001;63(4):202–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11408812
Roh JL, Pae KH, Choi SH, Kim JS, Lee S, Kim SB, Nam SY, Kim SY. 2-[18F]-Fluoro-2-deoxy-D-glucose positron emission tomography as guidance for primary treatment in patients with advanced-stage resectable squamous cell carcinoma of the larynx and hypopharynx. Eur J Surg Oncol. 2007 Aug;33(6):790-5.